Dr. Reddy's Laboratories Limited (RDY)
NYSE - NYSE 延遲價格。貨幣為 USD。
加入追蹤清單
收市：04:00PM EDT
收市後：
損益表
貨幣 : INR. 所有數字以千元為單位細節
過去 12 個月
31/3/2024
31/3/2023
31/3/2022
31/3/2021
31/3/2020
總收益
279,164,000
-
245,879,000
214,391,000
189,722,000
174,600,000
收益成本
82,087,000
-
106,536,000
100,551,000
86,645,000
80,591,000
毛利
197,077,000
-
139,343,000
113,840,000
103,077,000
94,009,000
營運成本
研究發展
-
-
19,381,000
17,482,000
16,541,000
15,410,000
銷售、總務及行政
118,690,000
-
68,026,000
62,081,000
54,650,000
50,129,000
營運總成本
132,443,000
-
80,289,000
77,921,000
70,167,000
61,239,000
經營收入或虧損
64,634,000
-
59,054,000
35,919,000
32,910,000
32,770,000
利息支出
1,711,000
-
1,428,000
958,000
970,000
983,000
其他收益總數/支出淨額
9,087,000
-
1,561,000
-3,628,000
-6,353,000
-14,648,000
稅前收益
72,010,000
-
60,367,000
32,298,000
26,413,000
18,032,000
所得稅費用
16,231,000
-
15,300,000
8,730,000
9,175,000
-1,466,000
連續營業收益
55,779,000
-
45,067,000
23,568,000
17,238,000
19,498,000
淨收益
55,779,000
-
45,067,000
23,568,000
17,238,000
19,498,000
可分配給普通股股東的淨收入
55,779,000
-
45,067,000
23,568,000
17,238,000
19,498,000
基本每股盈利
306.20
335.22
271.43
142.08
103.94
-
攤薄每股盈利
305.55
334.59
270.85
141.69
103.65
-
基本平均股份
166,178
166,395
166,035
165,883
165,844
-
攤薄後平均股份
166,530
166,709
166,388
166,339
166,316
-
